Some residents near Medline’s manufacturing site in Glens Falls, New York, might have heard about recent news, but the impacts could extend much wider. The FDA has sent Medline a warning letter because their heart-lung bypass syringes have been flagged with patient safety concerns.
This isn’t just one isolated incident; the FDA has received hundreds of complaints about issues with these specific devices, suggesting a significant potential risk. The Glens Falls location, which creates both these syringes and related procedure kits, is now under regulatory review.
While the full scope of the problem for Saratoga County residents isn’t specified, it’s clear the FDA is concerned about patient safety linked to these Medline syringes. The agency is urging Medline to take immediate steps to address these defects and ensure the devices are safe for use.